While many conditions, such as Alzheimer, Parkinson, ALS, and ataxia, are predominantly characterized by elevated PAR levels and PARP1 overactivation, Huntington disease presents a striking exception, with reduced PAR levels and impaired PARP1 activity. This evidence concerns the gene PARP1 and juvenile Huntington disease.